Tenderwize
Retour à la recherche

Open House Discount Agreements for Sunitinib, ATC L01EX01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 163 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sunitinib, ATC L01EX01

30/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

30 / 100

Complexité

40 / 100

Facteurs de risque

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 31, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive pharmaceutical discount agreements for Sunitinib (ATC L01EX01)
  • Open house model with uniform terms for all participants
Afficher le résumé complet

Open house non-exclusive discount agreements (Rabattverträge) for pharmaceutical products containing the active ingredient Sunitinib (ATC L01EX01) with the AOK Rheinland-Pfalz/Saarland. The open house model allows any interested pharmaceutical company to conclude a contract without a competitive selection process. The maximum contract duration is 24 months, with the earliest start on 01.06.2025 and all contracts ending by 31.05.2027. Contracts can be joined monthly. The buyer reserves the right to replace open house contracts with exclusive contracts awarded through EU-wide tenders. The notice states it is not a formal public procurement under EU directives, but published voluntarily for transparency.

Risques

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Only authorized and marketable drugs in Germany (verified via Lauer-Taxe or AMIce database)
  • Proof of marketing authorization and pharmaceutical entrepreneur status

Administrative

  • Submission of signed contract documents by the deadline

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreements for Sunitinib, ATC L01EX01

Non-exclusive discount agreements for Sunitinib drugs. All interested pharmaceutical companies can participate. Contract terms are uniform, no individual negotiations. First contract start on 01.06.2025, initial submission deadline 30.04.2025. Later contracts possible monthly until 31.03.2027. The open house agreements may be terminated early if the buyer concludes exclusive contracts.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 31, 2027

Détails de la procédure

Date de publication
10 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
235482-2025

Documents (1)

Appels d'offres similaires